Home » Author Archives: Catherine Skari (page 2)

Author Archives: Catherine Skari

Delegation visit to Oman – 10-11 September 2019

A TIF Delegation Visit to Oman took place on 10 – 11 September 2019 as a follow up to the 2017 visit which was conducted at the request of the Ministry of Health for the provision of technical expertise for the development of a comprehensive national control programme for thalassaemia ...

Read More »

TIF joined the Celgene’s Blood Transfusion Round Table Discussion in Brussels

On September 26, a Blood Transfusion Multi-Stakeholder Round Table Discussion was organised in Brussels by Celgene Corporation, featuring numerous scientists, haematologists, and patient organisations‘ representatives. Dr. Androulla Eleftheriou, TIF Executive Director, and Mrs. Lily Cannon, TIF Operations Manager, represented the Federation in this meeting. The discussion drew attention to issues ...

Read More »

TIF welcomes landmark UN declaration on Universal Health Coverage

A firm message in favour of achieving World Health Organization’s (WHO) number 1 goal, thus the provision of Universal Health Coverage (UHC) to citizens of all countries at a global scale, was sent by  world leaders yesterday, September 23, during the 74th UN General Assembly taking place in New York. ...

Read More »

Cypriot Stella Kyriakides named EU Health Commissioner

Cypriot psychologist and politician to take over from Vytenis Andriukaitis on November 1 Stella Kyriakides has got the nod as EU Commissioner for Health, making her part of a strong female presence in the new structure of the next European Commission. Kyriakides, one of 13 women commissioners from 27, replaces ...

Read More »

Delegation visit to Germany – 4-5 July 2019

A TIF delegation visit to Germany took place on 04 – 05 July 2019. The Delegation Team was comprised of Mr George Constantinou (TIF Secretary) and Dr Eva-Maria Knoll (TIF collaborator in Austria and the Maldives). The team was accompanied by Mr. Zabihullah Safai (Board Member of SAM Deutschland e.V. ...

Read More »

FDA Grants Priority Review to Potential Sickle Cell Disease Treatment Voxelotor

  The Food and Drug Administration (FDA) will review an approval application for a drug designed to target the root cause of damage from sickle cell disease (SCD). South San Francisco, California-based Global Blood Therapeutics announced Thursday that the FDA had accepted its application seeking accelerated approval for Voxelotor, an oral drug ...

Read More »

TIF releases new video on thalassaemia prevention

  Thalassaemia is a hereditary blood disease that CAN be prevented! But in what ways? ΤΙF’s latest educational video shines a spotlight on the essential aspect of the disease’s prevention, still challenging  in numerous countries across the world. Our goal? To further improve understanding and knowledge of the prevention’s vital ...

Read More »